Grifols, S.A. American Depositary Receipt (GRFS) at a glance
Grifols, S.A. American Depositary Receipt (GRFS) is a mid-cap Healthcare company. It trades at $7.55, with a P/E of 10.2, a 6.1% profit margin and revenue decline of 0.9%. It pays a 1.1% dividend yield. Vestovix scores it 59/100 overall. Its strongest dimension is Value (93/100) and its weakest is Momentum (26/100). Its volatility is roughly in line with the market.
- Price
- $7.55
- Market cap
- $5.27B
- P/E ratio
- 10.2
- Dividend yield
- 1.15%
- Beta
- 1.19
- 52-week range
- $6.96 to $10.23
Value
93
Growth
63
Income
49
Safety
38
Momentum
26
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,116.20-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$266.20+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$257.12-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$378.73-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$144.01-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.57+0.92%
2.16% yield
AMGN65
Amgen Inc.
$378.21-1.05%
2.76% yield